BTL Aesthetics Hits A New Milestone

EmSculpt toned stomach

The EmSculpt pioneers are celebrating one million EmSculpt and EmSculpt NEO treatments.

BTL Aesthetics has solidified its status as a game-changing aesthetics brand this week, hitting one million treatments of its innovative EmSculpt and EmSculpt NEO devices. The leading aesthetics device brand has seen phenomenal results across 58 countries and is officially the fastest to reach the one million milestone globally.

The milestone backs up BTL Aesthetics’ reputation as a global leader in medical and aesthetic equipment, backed by over 40 clinical publications and trials.

“We have over 300 BTL Aesthetics devices in place [around Australia] across the brands, including EmSculpt NEO, EmSculpt, Emsella and EmTone,” says Gareth Pepper, the company’s National Sales Director. “Many of our clinics have purchased one device and then have been so happy, that they have come back and bought multiple devices. We believe this is because of the independent clinical evidence that backs our technology, patient satisfaction, excellent sales support, fast responses times and a professional team.”

EmSculpt and EmSculpt NEO technology are clinically-proven to simultaneously burn fat and build muscle, delivering the equivalent of 20,000 sit-ups or squats in a single 30-minute session. The patented and ground-breaking HIFEM®+ technology has revolutionised non-invasive body shaping and contouring, delivering impressive and consistent results and patient satisfaction.

BTL Aesthetics prides itself on the safety and efficacy of its devices and is the most in-depth researched technology in the industry. The technology is the first TGA- and FDA-approved device to reduce intra-abdominal, visceral adipose tissue, or visceral fat. Until the introduction of EmSculpt, visceral fat could not be eliminated with non-surgical or surgical approaches, including liposuction. 

EmSculpt treatments have seen amazing results worldwide, with one clinical study revealing an increase of 15% in muscle mass and a nearly 20% reduction in fat cell deposits. The treatment is a perfect complement to a consistent core-building routine and a great alternative for those looking to resculpt their body after pregnancy or weight loss.

EmSculpt NEO goes one step futher than the standard EmSculpt treatment. The device combines RF and HIFEM+ energies in a single applicator, giving EmSculpt NEO the power to build 25% more muscle and reduce fat by 30% on average. Treatment areas include the abdomen, buttocks, arms, calves and flanks.

“We have achieved significant sales growth with Emsculpt NEO,” Pepper says. “We feel that our clients will reap the rewards of both Emsculpt and Emsculpt NEO as their clients emerge from lockdown, looking for advanced ways to burn fat, build muscle and kickstart their fitness and body goals.”

Globally renowned for impressive results, EmSculpt has proved to be hugely popular with celebrities including Megan Fox, Addison Rae and BTL Aesthetics partner Drew Barrymore. It’s even received the Kim Kardashian tick of approval; “It’s just this machine that you put on your stomach and it feels like you’re doing stomach crunches but you’re not. I’m into it,” the business mogul and reality star told her sister on Keeping Up with the Kardashians.

As for the future of BTL Aesthetics, Pepper says they have no plans on slowing down: “BTL Aesthetics plan for 2022 is to continue to dominate the market, with ground-breaking technology that others try to imitate but cannot replicate,” he explains. “BTL is always original and leads the aesthetic market, and we will continue to prove this position.”

DID YOU KNOW:

There are 5 ways you can catch up with SPA+CLINIC?

  1. Our quarterly print magazine, delivered to your door. Subscribe here.
  2. Our website, which is updated daily with its own completely unique content and breaking news.
  3. Our weekly newsletter – free to your inbox! Subscribe here.
  4. Our digital magazine – click here to view previous issues.
  5. Our social media – see daily updates on our InstagramFacebook Linkedin

Recommended Articles

SHORTLIST 0